Dornase alfa vs placebo or no dornase alfa treatment
Quality of life: CFQ‐R respiratory domain: absolute change from baseline · adults and children with cystic fibrosis
Dornase alfa showed no clear difference in change in quality of life ‐ CFQ‐R respiratory at 1 month compared with placebo or no dornase alfa treatment (low certainty).
2 findings from 1 review
- MD 0.8419 participantsLow
- MD 9.7819 participantsLow